AN2 Therapeutics reported total assets of $81.68M and total liabilities of $5.75M for the quarter ended Jun 2026, up 7.7% year over year. This balance sheet covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 12.10M | 82.52M | 40.62M | 28.80M | 27.22M | 26.71M | 40.81M | 32.62M | 15.65M | 24.70M | 26.80M | 33.50M | 21.40M | 20.00M | 18.22M | 18.00M | 19.94M | 53.50M | 44.32M | |||
| Receivables - OtherOther Receivables | 0.20M | 0.20M | 0.20M | 0.50M | 0.40M | 0.40M | 0.30M | 0.30M | 0.30M | 0.30M | 0.40M | 0.40M | 0.40M | 0.30M | 0.30M | |||||||
| Prepaid Assets | 1.55M | 1.40M | 3.48M | 2.84M | 2.51M | 1.77M | 2.94M | 2.59M | 3.21M | 2.10M | 2.90M | 4.26M | 2.64M | 2.50M | 4.61M | 2.10M | 1.94M | 2.20M | 1.60M | |||
| Current Assets | 60.11M | 119.78M | 116.88M | 107.30M | 98.62M | 90.32M | 98.21M | 126.41M | 110.51M | 116.31M | 107.44M | 97.69M | 86.26M | 69.56M | 67.52M | 64.02M | 59.94M | 87.49M | 79.99M | |||
| Non-Current Assets | ||||||||||||||||||||||
| Long-Term Investments | 3.49M | 2.42M | 1.99M | 3.22M | 26.36M | 27.19M | 3.90M | 5.02M | 11.48M | 8.30M | 3.22M | 2.01M | 1.47M | |||||||||
| Other Non-Current Assets | 0.72M | 0.72M | 0.72M | 0.72M | 0.72M | 0.72M | 1.04M | 1.04M | 1.04M | 1.04M | 0.80M | 0.30M | 0.22M | |||||||||
| Non-Current Assets | 5.21M | 0.72M | 3.14M | 2.71M | 3.94M | 0.77M | 0.72M | 27.40M | 28.24M | 4.95M | 1.04M | 5.83M | 11.78M | 8.30M | 3.22M | 2.01M | 1.69M | |||||
| Assets | 65.32M | 120.50M | 120.02M | 110.01M | 102.56M | 91.08M | 98.93M | 153.81M | 138.74M | 121.26M | 108.48M | 97.69M | 92.09M | 81.34M | 75.83M | 67.23M | 61.95M | 87.49M | 81.68M | |||
| Liabilities | ||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||
| Accounts Payables | 1.06M | 2.61M | 1.61M | 1.44M | 2.12M | 3.54M | 3.13M | 4.88M | 2.68M | 2.43M | 1.89M | 1.71M | 3.32M | 3.07M | 2.11M | 2.23M | 3.02M | 2.62M | 1.97M | |||
| Payables | 1.06M | 2.61M | 1.61M | 1.44M | 2.12M | 3.54M | 3.13M | 4.88M | 2.68M | 2.43M | 1.89M | 1.71M | 3.32M | 3.07M | 2.11M | 2.23M | 3.02M | 2.62M | 1.97M | |||
| Accumulated Expenses | 1.40M | 2.10M | 1.80M | 1.80M | 2.84M | 4.24M | 6.44M | 6.79M | 6.68M | 6.91M | 5.84M | 4.92M | 4.45M | 4.04M | 2.95M | 2.71M | 2.42M | 1.77M | 1.75M | |||
| Other Accumulated Expenses | 0.04M | 0.03M | 0.01M | 0.12M | 0.04M | 0.97M | 0.67M | 0.32M | 0.56M | 1.27M | 0.79M | 0.37M | 0.72M | 0.18M | 1.23M | 0.57M | 0.78M | |||||
| Current Leases | 0.03M | 0.01M | 0.07M | 0.05M | 0.03M | 0.01M | ||||||||||||||||
| Total Current Liabilities | 3.40M | 5.09M | 4.15M | 4.43M | 7.19M | 8.57M | 11.16M | 14.84M | 14.04M | 10.02M | 10.24M | 8.72M | 5.56M | 5.58M | ||||||||
| Non-Current Liabilities | ||||||||||||||||||||||
| Preferred Stock Liabilities | 107.39M | 109.32M | ||||||||||||||||||||
| Other Non-Current Liabilities | 0.17M | 0.17M | 0.17M | |||||||||||||||||||
| Total Non-Current Liabilities | 10.24M | 8.72M | 5.56M | 5.58M | ||||||||||||||||||
| Total Liabilities | 38.35M | 3.41M | 5.09M | 4.15M | 4.43M | 7.19M | 8.57M | 11.16M | 14.84M | 14.04M | 10.66M | 10.13M | 10.02M | 10.24M | 8.01M | 6.98M | 6.86M | 8.89M | 5.73M | 5.75M | ||
| Shareholder's Equity | ||||||||||||||||||||||
| Common Equity | -38.35M | -47.41M | 115.41M | 115.86M | 105.57M | 95.37M | 82.52M | 87.76M | 138.97M | 124.70M | 110.60M | 98.35M | 87.67M | 81.85M | 73.33M | 68.84M | 60.38M | 53.06M | 81.76M | 75.92M | ||
| Liabilities and Shareholders Equity | 65.32M | 120.50M | 120.02M | 110.01M | 102.56M | 91.08M | 98.93M | 153.81M | 138.74M | 121.26M | 108.48M | 97.69M | 92.09M | 81.34M | 75.83M | 67.23M | 61.95M | 87.49M | 81.68M | |||
| Retained Earnings | -47.38M | 171.99M | 182.76M | 184.00M | 185.47M | 187.74M | 208.73M | 276.65M | 278.88M | 281.62M | 283.89M | 285.81M | 287.59M | 289.71M | 291.70M | 292.55M | 293.95M | 332.74M | 335.11M | |||
| Treasury Shares | 11.41M | 11.41M |